Home » Molecular Matrix Snags FDA Clearance for Bone Graft Technology
Molecular Matrix Snags FDA Clearance for Bone Graft Technology
Molecular Matric received FDA 510(k) clearance for its musculoskeletal technology for bone regeneration – Osteo-P.
The bone graft substitute is made with a hyper-crosslinked carbohydrate polymer.
The musculoskeletal solution is intended for filling bone defects caused by surgical procedures or traumatic injuries.
Upcoming Events
-
21Oct